[Neurogenic bladder dysfunction in infants and its treatment (author's transl)].
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D002404:Catheterization; D004558:Electric Stimulation; D004566:Electrodes; D006801:Humans; D007223:Infant; D008722:Methods; D010138:Pacemaker, Artificial; D001743:Urinary Bladder / Q000294:innervation; D001750:Urinary Bladder, Neurogenic / Q000601:surgery / Q000628:therapy*; D014549:Urinary Incontinence / Q000628:therapy
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists
Zur Therapie neurogener Blasenentleerungsstörungen bei Kindern.